Schrodinger, Inc.
SDGR- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001490978
In the last 90 days, Schrodinger, Inc. insiders filed 0 open-market purchases and 2 sales; 231 institutions reported holding it in 13F filings for Q2 2026, worth $1.05B in total; superinvestors Gates Foundation Trust and ARK Invest hold it.
Open-market trades, last 90 days
Open-market purchases (P) and sales (S) by Schrodinger, Inc. insiders, counted by Form 4 filing. Trades with a flagged price and duplicate filings are left out.
- Open-market buys
- 0 filings
- Open-market sells
- 2 filings
- 2 insiders, $941.6K in total
- Insiders trading
- 2
- Net value
- −$941.6K
- Purchases minus sales
Insider roster
Directors, officers and 10% owners who have filed a Form 4 for Schrodinger, Inc., current and former, most recent filer first. Last reported holding is the position after the last non-derivative trade in their latest filing.
| Name | Title | Last reported holding | Last filing | Filings, past year |
|---|---|---|---|---|
| Akinsanya Karen | See Remarks | 69,956 | Sep 21, 2026 | 3 |
| Jain Rachit | EVP & CFO | 50,877 | Jul 17, 2026 | 4 |
| Friesner Richard | Director | 679,373Indirect | Jun 29, 2026 | 3 |
| Ginsberg Gary L | Director | 25,388 | Jun 23, 2026 | 1 |
| Oberoi Arun | Director | 25,388 | Jun 23, 2026 | 1 |
| van Kralingen Bridget A | Director | 19,640 | Jun 23, 2026 | 1 |
| Lynton Michael | Director | 25,388 | Jun 23, 2026 | 1 |
| Chodakewitz Jeffrey | Director | 25,388 | Jun 23, 2026 | 1 |
| Sender Gary | Director | 25,388 | Jun 23, 2026 | 1 |
| Thornberry Nancy | Director | 25,388 | Jun 23, 2026 | 1 |
| Kapeller-Libermann Rosana | Director | 25,388 | Jun 23, 2026 | 1 |
| Farid Ramy | President & CEO | 405,351 | Apr 17, 2026 | 3 |
| Lorton Kenneth Patrick | EVP, CTO & COO, Software | 89,241 | Mar 6, 2026 | 3 |
| Tran Yvonne | EVP, CLO & CPO | 52,683 | Mar 6, 2026 | 3 |
| Herman Jenny | CAO | 34,804 | Mar 6, 2026 | 3 |
| Abel Robert Lorne | See Remarks | 55,897 | Mar 6, 2026 | 3 |
| Aklian Mannix Vartan | See Remarks | 31,193 | Mar 3, 2026 | 1 |
| Dugan Margaret | Chief Medical Officer | 24,574 | Oct 17, 2025 | 1 |
| Porges Geoffrey Craig | EVP & CFO | 27,544 | Mar 4, 2025 | 0 |
| Lebowitz Joel | EVP & CFO | 0 | Sep 3, 2021 | 0 |
| Shaw David E | 10% Owner | 6,103,042Indirect | Jul 19, 2021 | 0 |
| Schrodinger Equity Holdings, LLC | 10% Owner | 6,103,042Indirect | Jul 19, 2021 | 0 |
Insider trades
Each row adds up one type of transaction in one Form 4 filing. Only open-market purchases (P) and sales (S) are shown by default; use the filters to see grants, option exercises and other codes.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Jul 14, 2021 (view filing)6:23 PM ET | Jul 12-14 | 2 days | Shaw David E and 1 other10% Owner | SSaleCommon Stock, par value $0.01 per share | −106.2K | $70.58 | −$7.50M | −1.7%6.25M after | 11 lots |
| Jul 9, 2021 (view filing)6:12 PM ET | Jul 8-9 | 1 day | Shaw David E and 1 other10% Owner | SSaleCommon Stock, par value $0.01 per share | −56.9K | $74.58 | −$4.25M | −0.9%6.36M after | 8 lots |
| Jul 7, 2021 (view filing)6:47 PM ET | Jul 6-7 | 1 day | Shaw David E and 1 other10% Owner | SSaleCommon Stock, par value $0.01 per share | −58.1K | $74.06 | −$4.30M | −0.9%6.42M after | 7 lots |
| Jul 2, 2021 (view filing)5:42 PM ET | Jul 1-2 | 1 day | Shaw David E and 1 other10% Owner | SSaleCommon Stock, par value $0.01 per share | −60.2K | $76.03 | −$4.58M | −0.9%6.48M after | 6 lots |